[Suppression of peritoneal implantation by NK4 and its mechanisms]
Kiyoto Atsuji1, Hitoshi Fujiwara, Takeshi Kubota
1Dept. of Surgery and Oncology of Digestive System, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.
Abstract:
NK4 suppresses invasion and metastasis of tumor cells by means of dual actions as HGF antagonist and angiogenesis inhibitor. Our previous studies showed that NK4 suppresses the implantation of tumor cells to the peritoneal milky spots (MS) by intraperitoneal injection (i.p.) of adenovirus vector expressing NK4 (Ad-NK4) or NK4 gene-transfected tumor cells. In the present study, we investigated the antitumor mechanisms of NK4 in the suppression of peritoneal implantation. When evaluated by a fluorescent microscopy, a prior injection of Ad-NK4 suppressed peritoneal implantation immediately after the injection of GFP-expressing tumor cells. DNA microarray analyses also demonstrated a reduced expression of some adhesion molecules in NK4 gene-transfected tumor cells as compared to neomycin gene-trasfected cells (control). In the in vitro adhesion assay, the adhesion to some types of the extra cellular matrixs (ECM) was significantly decreased in NK4 gene-transfected cells as compared to the control. These results suggest that NK4 may suppress peritoneal implantation by inhibiting adhesion of tumor cells to ECM around MS.
Insights
NK4 protein inhibits tumor cell spread by blocking cell adhesion to the extracellular matrix. This study reveals NK4
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Tumor cell metastasis and peritoneal implantation are critical challenges in cancer treatment.
- Hepatocyte Growth Factor (HGF) and angiogenesis play significant roles in tumor progression.
- Previous work demonstrated NK4's potential to suppress tumor cell implantation.
Purpose:
- To elucidate the antitumor mechanisms of NK4 in suppressing peritoneal tumor cell implantation.
- To investigate NK4's effect on tumor cell adhesion molecules and extracellular matrix (ECM) interactions.
Summary:
- Adenovirus-mediated NK4 (Ad-NK4) injection suppressed peritoneal tumor cell implantation.
- DNA microarray analysis revealed reduced expression of adhesion molecules in NK4-transfected tumor cells.
- In vitro assays showed decreased adhesion of NK4-transfected cells to ECM components.
Impact:
- NK4 exhibits antitumor effects by inhibiting tumor cell adhesion to the ECM.
- This mechanism contributes to the suppression of peritoneal metastasis.
- NK4 represents a potential therapeutic strategy for preventing cancer spread.
More Related Videos
10:36A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Published on: January 9, 2018
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
